Microfluidic device security

Mohammed Shayan; Tung Che Liang; Ramesh Karri; Krishnendu Chakrabarty

doi:10.1007/978-3-030-64448-2_20

Microfluidic device security

Mohammed Shayan, Tung Che Liang, Ramesh Karri, Krishnendu Chakrabarty

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Functional diversification is expected to drive the growth of hardware computing beyond the end of Moore's law. Medical application is expected to be a system driver of such diversification. Microfluidic technologies enable miniaturization of laboratory-based biochemical protocols. A microfluidic biochip or lab-on-a-chip (LoC) performs biochemical reactions by consuming nano-/pico-liter volume of reagents. These platforms use less volume of samples and reagents and provide quicker results than the traditional lab. Also, these platforms enable automation that reduces the reliance on high-skilled personnel. Digital microfluidic biochip (DMFB) and continuous flow-based microfluidic biochip (CFMB) are examples of such biochip platforms. CFMBs manipulate fluid flow through a network of micro-channel by actuating pressure-driven micro-valves. DMFB offers a programmable fluidic platform in which discrete fluid droplets can be manipulated through electrical actuations.

Original language	English (US)
Title of host publication	Emerging Topics in Hardware Security
Publisher	Springer International Publishing
Pages	555-577
Number of pages	23
ISBN (Electronic)	9783030644482
ISBN (Print)	9783030644475
DOIs	https://doi.org/10.1007/978-3-030-64448-2_20
State	Published - Jun 1 2021

ASJC Scopus subject areas

General Engineering
General Computer Science

Access to Document

10.1007/978-3-030-64448-2_20

Cite this

@inbook{55859509b0b0409da0462708dafbf3f7,

title = "Microfluidic device security",

abstract = "Functional diversification is expected to drive the growth of hardware computing beyond the end of Moore's law. Medical application is expected to be a system driver of such diversification. Microfluidic technologies enable miniaturization of laboratory-based biochemical protocols. A microfluidic biochip or lab-on-a-chip (LoC) performs biochemical reactions by consuming nano-/pico-liter volume of reagents. These platforms use less volume of samples and reagents and provide quicker results than the traditional lab. Also, these platforms enable automation that reduces the reliance on high-skilled personnel. Digital microfluidic biochip (DMFB) and continuous flow-based microfluidic biochip (CFMB) are examples of such biochip platforms. CFMBs manipulate fluid flow through a network of micro-channel by actuating pressure-driven micro-valves. DMFB offers a programmable fluidic platform in which discrete fluid droplets can be manipulated through electrical actuations.",

author = "Mohammed Shayan and Liang, {Tung Che} and Ramesh Karri and Krishnendu Chakrabarty",

year = "2021",

month = jun,

day = "1",

doi = "10.1007/978-3-030-64448-2_20",

language = "English (US)",

isbn = "9783030644475",

pages = "555--577",

booktitle = "Emerging Topics in Hardware Security",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Microfluidic device security

AU - Shayan, Mohammed

AU - Liang, Tung Che

AU - Karri, Ramesh

AU - Chakrabarty, Krishnendu

PY - 2021/6/1

Y1 - 2021/6/1

N2 - Functional diversification is expected to drive the growth of hardware computing beyond the end of Moore's law. Medical application is expected to be a system driver of such diversification. Microfluidic technologies enable miniaturization of laboratory-based biochemical protocols. A microfluidic biochip or lab-on-a-chip (LoC) performs biochemical reactions by consuming nano-/pico-liter volume of reagents. These platforms use less volume of samples and reagents and provide quicker results than the traditional lab. Also, these platforms enable automation that reduces the reliance on high-skilled personnel. Digital microfluidic biochip (DMFB) and continuous flow-based microfluidic biochip (CFMB) are examples of such biochip platforms. CFMBs manipulate fluid flow through a network of micro-channel by actuating pressure-driven micro-valves. DMFB offers a programmable fluidic platform in which discrete fluid droplets can be manipulated through electrical actuations.

AB - Functional diversification is expected to drive the growth of hardware computing beyond the end of Moore's law. Medical application is expected to be a system driver of such diversification. Microfluidic technologies enable miniaturization of laboratory-based biochemical protocols. A microfluidic biochip or lab-on-a-chip (LoC) performs biochemical reactions by consuming nano-/pico-liter volume of reagents. These platforms use less volume of samples and reagents and provide quicker results than the traditional lab. Also, these platforms enable automation that reduces the reliance on high-skilled personnel. Digital microfluidic biochip (DMFB) and continuous flow-based microfluidic biochip (CFMB) are examples of such biochip platforms. CFMBs manipulate fluid flow through a network of micro-channel by actuating pressure-driven micro-valves. DMFB offers a programmable fluidic platform in which discrete fluid droplets can be manipulated through electrical actuations.

UR - http://www.scopus.com/inward/record.url?scp=85150144109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150144109&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-64448-2_20

DO - 10.1007/978-3-030-64448-2_20

M3 - Chapter

AN - SCOPUS:85150144109

SN - 9783030644475

SP - 555

EP - 577

BT - Emerging Topics in Hardware Security

PB - Springer International Publishing

ER -

Microfluidic device security

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this